Management of Nuchal Translucency 1.6 mm
A nuchal translucency measurement of 1.6 mm at 11-14 weeks gestation is within normal limits and requires routine first-trimester combined screening with maternal serum markers (PAPP-A and free β-hCG) to complete aneuploidy risk assessment, followed by standard prenatal care.
Understanding the Measurement
An NT of 1.6 mm falls well below the threshold for concern. The critical cut-off that triggers additional intervention is ≥3.0 mm or above the 99th percentile 1. Your measurement is approximately at or below the 50th percentile for most gestational ages in the first trimester, representing a completely normal finding.
Recommended Management Algorithm
1. Complete First-Trimester Combined Screening
- Proceed with maternal serum marker testing (PAPP-A and free β-hCG) if not already done
- The NT measurement alone should not be used in isolation; it must be combined with biochemical markers and maternal age to calculate accurate risk 2, 1
- This combined approach detects approximately 90% of trisomy 21 cases at a 5% false-positive rate 1
2. No Additional Testing Required
- Do NOT repeat the NT measurement - Research demonstrates that repeat measurements for NT values in the lower range (≤1.6 mm at most gestational ages) provide no additional benefit due to truncation limits applied in risk calculations 3
- No indication for early fetal echocardiography, as this is reserved for NT ≥3.0 mm 1
- No indication for Doppler studies (ductus venosus, tricuspid regurgitation), which should be reserved for at-risk fetuses with NT ≥3.0 mm 1
3. Standard Prenatal Care
- Proceed with routine second-trimester anatomic survey at 18-22 weeks
- No need for enhanced fetal surveillance or additional cardiac evaluation
- Standard genetic counseling based on combined first-trimester screening results and maternal age
Key Clinical Context
The evidence clearly distinguishes management based on NT thresholds:
- NT <3.0 mm: Routine care with combined screening 1
- NT ≥3.0 mm: Triggers genetic counseling, consideration of invasive testing (CVS/amniocentesis), cell-free DNA testing, second-trimester fetal echocardiogram, and detailed anatomic survey 1
Recent data confirms that even NT measurements between 2.5-3.4 mm with normal ultrasound findings carry only a 2% risk of trisomy 13,18, or 21 4. Your measurement of 1.6 mm is substantially lower than this range.
Important Caveats
- Wait for combined screening results: The NT measurement must be interpreted alongside maternal serum markers. A low NT does not eliminate all risk, which is why biochemical markers are essential 2
- Risk cut-offs: Most programs use a first-trimester risk cut-off of 1:200 (equivalent to a 35-year-old patient's risk), though 1:150 or 1:270 are also acceptable 2
- If screen-positive on combined testing: Even with normal NT, elevated risk from combined screening warrants genetic counseling and discussion of cell-free DNA testing or invasive diagnostic testing
What NOT to Do
- Do not pursue invasive testing based solely on this NT measurement
- Do not order early fetal echocardiography
- Do not repeat the NT measurement seeking a "better" value
- Do not skip the maternal serum marker component of first-trimester screening
The bottom line: An NT of 1.6 mm is reassuring and requires only completion of standard first-trimester combined screening followed by routine prenatal care 2, 1.